CP
DDS icon

Castleview Partners’s Dillards DDS Stock Holding History

Castleview Partners’s Portfolio DDS Stock Details DDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$54K Buy
+301
New +$38.8K 0.02% 393

Other funds holding DDS

Newport Trust Company
Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Castleview Partners's DDS Position: Q2 2021 in Review

Castleview Partners opened a new position in Dillards (DDS) in Q2 2021: 301 shares worth $54K. The stake represents 0.02% of the portfolio and ranks #393 among its holdings.

156 funds tracked by Wall St. Rank hold DDS as of Q2 2021.

  • Castleview Partners held 301 shares of Dillards worth $54K as of Q2 2021.
  • Dillards was a new Castleview Partners position in Q2 2021.
  • Dillards made up 0.02% of Castleview Partners's portfolio in Q2 2021, its #393 holding.
  • 156 funds tracked by Wall St. Rank held Dillards as of Q2 2021.

Based on Castleview Partners's 13F filing for Q2 2021, filed 17 Aug 2021.